12:00 AM
 | 
Jul 24, 2000
 |  BC Week In Review  |  Company News  |  Other News

EntreMed, Abbott cancer news

ENMD filed a counterclaim in the U.S. District Court for the District of Massachusetts to ABT's May suit claiming that an ABT scientist discovered the anti-angiogenic...

Read the full 106 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >